|
ZNF625 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.76389999995141E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.72180000000055E-05 |
| Normal-vs-Stage2 |
1.201840E-01 |
| Normal-vs-Stage3 |
2.45309999999943E-05 |
| Normal-vs-Stage4 |
2.37249999979205E-07 |
| Stage1-vs-Stage2 |
7.001500E-02 |
| Stage1-vs-Stage3 |
2.495600E-01 |
| Stage1-vs-Stage4 |
4.599300E-03 |
| Stage2-vs-Stage3 |
2.847700E-02 |
| Stage2-vs-Stage4 |
1.802210E-03 |
| Stage3-vs-Stage4 |
1.144610E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.55820000002915E-06 |
| Normal-vs-AfricanAmerican |
9.813800E-02 |
| Normal-vs-Asian |
9.037900E-04 |
| Caucasian-vs-AfricanAmerican |
2.572600E-01 |
| Caucasian-vs-Asian |
8.079000E-01 |
| AfricanAmerican-vs-Asian |
4.601200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.376500E-04 |
| Normal-vs-Female |
6.19250000000182E-05 |
| Male-vs-Female |
5.895400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.1722999999918E-05 |
| Normal-vs-Age(41-60Yrs) |
2.48399999999149E-05 |
| Normal-vs-Age(61-80Yrs) |
4.577700E-04 |
| Normal-vs-Age(81-100Yrs) |
1.812440E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.288800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.581800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.071800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.139800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.471800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.244400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.298010E-02 |
| Classical-VS-Follicular |
1.382000E-01 |
| Classical-VS-Other |
5.380200E-01 |
| Classical-VS-Normal |
1.632680E-04 |
| Tall-VS-Follicular |
2.602700E-03 |
| Tall-VS-Other |
6.940200E-01 |
| Tall-VS-Normal |
1.06939999999778E-06 |
| Follicular-VS-Other |
3.572800E-01 |
| Follicular-VS-Normal |
2.847600E-02 |
| Other-VS-Normal |
4.695900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.047200E-04 |
| Normal-vs-N1 |
8.45109999980664E-07 |
| N0-vs-N1 |
5.979800E-03 |
|
|
